化疗诱导的心脏毒性与前线BV-AVD对于霍奇金淋巴瘤
Angelo Rizzolo1, Caroline Michel2, Nathalie A Johnson1
1Division of Hematology, Jewish General Hospital, Montreal, Quebec, Canada, jgh.ca.
Case reports in oncological medicine
|December 31, 2025
概括
布伦图西马布维多丁 (BV) 与化疗一起有效治疗霍奇金淋巴瘤 (HL),但可能导致严重的副作用. 本案例报告详细介绍了BV引起的心脏毒性,强调需要仔细监测患者和进一步安全研究.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 心脏病学 心脏病学
背景情况:
- 布伦图西马布维多丁 (BV) 与化疗相结合是霍奇金淋巴瘤 (HL) 的公认治疗方法.
- 众所周知,这种疗法会增加外围神经病变和中性质减退的风险.
- 新出现的数据表明,随着使用BV的增加,可能会出现新的和意想不到的毒性.
研究的目的:
- 在霍奇金淋巴瘤治疗中报告与布伦图西马布维多丁和化疗相关的心脏毒性病例.
- 为了强调在这种治疗过程中对不良事件的警监测的重要性.
- 倡导进一步调查基于BV的治疗方案的风险因素,机制和长期安全性.
主要方法:
- 案例报告的呈现方式.
- 对临床表现和治疗过程的审查.
- 关于布伦图西马布维多丁毒性的文献综述.
主要成果:
- 在BV化疗治疗霍奇金淋巴瘤期间,患者出现心脏毒性.
- 这种不良事件是意想不到的,并突出了不太常见的毒性特征.
- 该案例强调了接受这种治疗的患者需要主动的心脏评估的必要性.
结论:
- 基于Brentuximab vedotin的化疗可以诱导显著的心脏毒性.
- 对于接受这种治疗的患者来说,对心脏不良事件的警监测至关重要.
- 需要进一步的研究来阐明BV诱导的心脏毒性的机制和长期影响.
相关概念视频
Heart Failure Drugs: Inotropic Agents
1.2K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.2K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
785
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
785
Cardiopulmonary Resuscitation IV: Pharmacological Management
570
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
570
Cardiomyopathy V: Interprofessional Care
310
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
310
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K


